Home | Contact Us | Forms | Events | News | Links

OTA Resources

Quick Links


Send Us Your Feedback

Available Technologies - Search Results

Title: Modulation Of Cell Growth And Growth Factor Signaling Through Removal Of Glypicans
UC Case No: 1998-280-5-ott
Categories: Biotechnology: Diagnostics, Drug Targets and Screening Tools
Background: Membrane associated heparin sulfate proteoglycans (HSPGs) have been shown to play important roles in many aspects of cell behavior, including cell-cell and cell-extracellular matrix adhesion and growth factor signaling. Glypicans, members of the HSPGs, are a family of polypeptides that appear to carry the majority of the heparin sulfate on mammalian cells. These glypicans are attached to the plasma membrane via glycosylphophatidylinositol (GPI) anchors.
Technology: Glycosylphosphatidylinositol-(GPI-) anchored HSPG glypican-1 (glypican-1) is strongly expressed in human breast and pancreatic cancer - both by the cancer cells and in the case of pancreatic cancer the adjacent fibroblasts. Expression of glypican-1 is low in normal pancreas and breast tissue. Pancreatic cancer cell lines that express glypican-1 were treated with the enzyme phosphinositide-specific phospholipase-C (PI-PLC) which enzymatically removes glypicans from the cell surface by cleaving the GPI anchors. This treatment resulted in the abrogation of the cells' mitogenic response to two heparin-binding growth factors. Treatment of breast cancer cell lines also abrogated their response to two different heparin-binding growth factors.
Application: Glypican-1 can be used for the diagnosis and screening for the occurrence of breast and pancreatic cancer. Glypican-1 can also be targeted with small molecules and biologics to retard the growth of glypican-responsive cancers.
Contact: Ronnie Hanecak, Ph.D., Associate Vice Chancellor (Interim)
Office of Technology Alliances
University of California, Irvine
380 University Tower
Irvine, CA 92697-7700

Phone: (949) 824-7186
FAX: (949) 824-2899
Email: rhanecak@uci.edu
Patent Status: Pending
UCI School: College of Medicine
Department: Department of Medicine - Endocrinology